Bausch Health's taken a hit, trading lower than expected. The Q1 adjusted EPS and sales results were worse than anticipated, and the company’s revenue for the quarter saw a decline of 5.4% YoY, bringing it to $1.92 billion. Looking ahead, Bausch Health is predicting revenue for 2022 to be in the range of $8.25 billion to $8.40 billion, which falls short of the $8.56 billion consensus. The company is also projecting a full-year adjusted EBITDA of up to $3.375 billion (non-GAAP).
https://beststocks.com/bausch-healths-q1-results-fall-short-causing/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.